APA (7th ed.) Citation

BE, F., TC, M., SR, F., CR, K., MP, P., KB, P., . . . EJ, V. (2023). Long-term outcomes with reduced-dose whole-brain radiotherapy and a stereotactic radiosurgery boost for primary central nervous system lymphoma. Neuro-oncology advances, 5(1), vdad097. https://doi.org/10.1093/noajnl/vdad097

Chicago Style (17th ed.) Citation

BE, Foreman, Mullikin TC, Floyd SR, Kelsey CR, Patel MP, Peters KB, Kirkpatrick JP, Reitman ZJ, and Vaios EJ. "Long-term Outcomes with Reduced-dose Whole-brain Radiotherapy and a Stereotactic Radiosurgery Boost for Primary Central Nervous System Lymphoma." Neuro-oncology Advances 5, no. 1 (2023): vdad097. https://doi.org/10.1093/noajnl/vdad097.

MLA (9th ed.) Citation

BE, Foreman, et al. "Long-term Outcomes with Reduced-dose Whole-brain Radiotherapy and a Stereotactic Radiosurgery Boost for Primary Central Nervous System Lymphoma." Neuro-oncology Advances, vol. 5, no. 1, 2023, p. vdad097, https://doi.org/10.1093/noajnl/vdad097.